Acrivon Therapeutics, Inc. Common Stock

General ticker "ACRV" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $77.3M (TTM average)

Acrivon Therapeutics, Inc. Common Stock follows the US Stock Market performance with the rate: 43.5%.

Estimated limits based on current volatility of 4.9%: low 1.65$, high 1.82$

Factors to consider:

  • Total employees count: 41 as of 2022
  • Price in estimated range
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [1.45$, 4.84$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.30$, 4.29$]

Financial Metrics affecting the ACRV estimates:

  • Positive: with PPE of -1.2 at the end of fiscal year the price was neutral
  • Negative: Operating cash flow per share per price, % of -70.62 <= 0.02
  • Negative: negative Operating income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Investing cash flow per share per price, % of 73.32 > -0.63
  • Positive: Shareholder equity ratio, % of 86.74 > 64.15
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: negative Net income

Similar symbols

Short-term ACRV quotes

Long-term ACRV plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $67.10MM $89.20MM $84.11MM
Operating Income $-67.10MM $-89.20MM $-84.11MM
Non-Operating Income $6.71MM $8.64MM $6.21MM
R&D Expense $46.02MM $63.99MM $59.99MM
Income(Loss) $-60.39MM $-80.56MM $-77.91MM
Profit(Loss)* $-60.39MM $-80.56MM $-77.91MM
Stockholders Equity $121.19MM $176.79MM $112.52MM
Assets $138.26MM $196.59MM $129.72MM
Operating Cash Flow $-42.64MM $-65.67MM $-63.66MM
Capital expenditure $1.29MM $2.77MM $1.67MM
Investing Cash Flow $50.72MM $-51.77MM $66.10MM
Financing Cash Flow $-1.55MM $121.03MM $-0.75MM
Earnings Per Share** $-2.74 $-2.10 $-2.02

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.